The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in Pyxa Systems (Pyxa or DirectusPro), a software development company focused on process-enabled technology solutions for regulatory and compliance functions within the global pharmaceutical industry. Pyxa is an add-on investment to Riverside’s latest platform Red Nucleus Enterprises, LLC, (RN), a premier provider of learning, performance and process solutions for the life sciences industry. Pyxa’s flagship software product DirectusPro is a unique global label management, tracking and reporting workflow solution that ensures efficient information flow and compliance practices for global pharmaceutical label development.
Read the full article: Riverside Invests in Pyxa Systems //
Source: https://www.riversidecompany.com/currents/riverside-continues-its-focus-on-the-gold-standard